Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

DGTL Voices with Ed Marx

A Positive Culture of Patient Care and Community Impact (ft. Sowmya Viswanathan, MD)

24 Apr 2024

Description

In this episode of DGTL Vocies, Ed welcomes Dr. Sowmya Viswanathan, the Chief Physician Executive for BayCare Health System. Sowmya shares a love for music, embracing both Indian classical and Taylor Swift, and discusses a life philosophy rooted in constant and never-ending improvement, as well as a mantra of positive intent. The conversation explores her journey from India to the United States, touching on various roles in healthcare leadership and the positive culture at BayCare, where patient care and community impact are central. With insights into BayCare's initiatives to support clinicians and reduce burnout, they talk a bit about Dr. Sowmya's role as Chief Physician Executive. Emphasizing the importance of technology and innovation in healthcare, Sowmya underscores the need for continuous learning and collaboration among leaders. Takeaways Sowmya Viswanathan's life message is constant and never-ending improvement, and her mantra is positive intent. BayCare has a positive culture focused on patient care and community impact. The role of the Chief Physician Executive involves operational responsibilities and collaboration with other leaders. BayCare is implementing technology initiatives to support clinicians and reduce burnout, such as AI-enabled documentation tools and a flexible hybrid workforce. Sowmya emphasizes the importance of continuous learning, attending conferences, and staying up-to-date with healthcare trends. Family and a support system are crucial for personal and professional success.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.